Management of Endometriosis: An Integrative Review of National and International Guidelines

In: Advances in Social Sciences Research Journal · 2023 · vol. 10(11) , pp. 328–342 · doi:10.14738/assrj.1011.15985 · W4389843996
article OA: diamond CC0

Abstract

Endometriosis is a disease characterized by the presence of endometrial tissue outside the uterus, affecting 2 to 22% of women worldwide, resulting in inferior quality of life as the condition often causes pain (dysmenorrhea, dyspareunia) and infertility. It is notable that clinical practice has changed in the last decade, with endometriosis receiving much more media attention and patients taking a more active role through different disease organizations. Considering these changes and identifying which practices are justified by medical evidence is essential. Using the descriptors: "Treatment", "Endometriosis" and "Guidelines" in the PUBMED, MEDLINE and SciELO databases, a total of 312 articles were found and, subsequently, eight articles were submitted to the selection criteria. Regarding pharmacological therapies associated with endometriosis, most of the guidelines included in this study suggest progestins, either in the form of dienogest or medroxyprogesterone acetate, and combined oral contraceptives as first-line therapy with considerable evidence. GNRH agonists and the levonorgestrel system are used as second-line treatment. Surgery also has a significant role in the treatment of endometriosis-related pain, with the excision of endometrial implants or endometriomas. Handling ovarian tissue as thoroughly as possible is recommended in order to limit the decrease in ovarian reserve. Despite very well-established guidelines, relevant diagnostic tests such as Magnetic Resonance Imaging (MRI) are inaccessible and expensive for most women, as is laparoscopic surgery, hindering the diagnosis and treatment of the disease, especially in underdeveloped countries.
Full text 2,299 characters · extracted from oa-html · click to expand
Management of Endometriosis: An Integrative Review of National and International Guidelines DOI: https://doi.org/10.14738/assrj.1011.15985Keywords: endometriosis, guidelines, diagnosis, managementAbstract Endometriosis is a disease characterized by the presence of endometrial tissue outside the uterus, affecting 2 to 22% of women worldwide, resulting in inferior quality of life as the condition often causes pain (dysmenorrhea, dyspareunia) and infertility. It is notable that clinical practice has changed in the last decade, with endometriosis receiving much more media attention and patients taking a more active role through different disease organizations. Considering these changes and identifying which practices are justified by medical evidence is essential. Using the descriptors: "Treatment", "Endometriosis" and "Guidelines" in the PUBMED, MEDLINE and SciELO databases, a total of 312 articles were found and, subsequently, eight articles were submitted to the selection criteria. Regarding pharmacological therapies associated with endometriosis, most of the guidelines included in this study suggest progestins, either in the form of dienogest or medroxyprogesterone acetate, and combined oral contraceptives as first-line therapy with considerable evidence. GNRH agonists and the levonorgestrel system are used as second-line treatment. Surgery also has a significant role in the treatment of endometriosis-related pain, with the excision of endometrial implants or endometriomas. Handling ovarian tissue as thoroughly as possible is recommended in order to limit the decrease in ovarian reserve. Despite very well-established guidelines, relevant diagnostic tests such as Magnetic Resonance Imaging (MRI) are inaccessible and expensive for most women, as is laparoscopic surgery, hindering the diagnosis and treatment of the disease, especially in underdeveloped countries. Downloads Published How to Cite Issue Section License Copyright (c) 2023 Ana Paula Portela Andrade, Clara Vitória Braz Lima de Oliveira, Luísa Barros Fragoso de Araújo, Maria Eduarda Dantas Donald, Fernanda Freire Dantas Portugal, Meyrielle Santana Costa, Carolina Portela de Andrade, Bruna Lins Chianca, Elizabeth Bacha This work is licensed under a Creative Commons Attribution 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrheadyspareuniainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK